Goodwin’s Private Equity team advised investment fund IK Partners on the acquisition of Sterimed Group as part of a management-led consortium. The consortium included long-term investor Sagard, as well as a club of new investors Société Générale CP, Geneo CE, Capza and Investir pour l’Enfance, under the name of “Friends of Sterimed”.
Founded in 2016 by Thibaut Hyvernat, who led a carve-out from Arjowiggins, Sterimed has established itself as a leading player in the manufacturing of integrated sterile flexible medical packaging for medical device manufacturers, hospitals and the pharmaceutical industry.
With the support of the entire consortium, Sterimed aims to drive continued organic growth by expanding globally into new markets. The Company also plans to support innovation in core and new markets, pursue further acquisitions and enter strategic adjacent sectors such as Pharma and Life Sciences.
The Goodwin team included:
- In Paris, Maxence Bloch, Aurélien Diday, William Ducrocq-Ferré and Sarah Louifi on corporate aspects;
- In London, Sarah Jordan, Charlotte Brunsdon and Anuj Ghai on antitrust regulatory aspects.